The great Brian Durie, M.D. presenting the great work from International Myeloma Foundation #mmsm #myeloma #blackswan iStopMM

Me and Jóhann Páll Hreinsson who have been supervising Arnar Bragi Ingason, were very proud when he presented at DDW and received an early investigator award

Helgi kristinn Björnsson MD, gave two presentations at the DDW today on Drug-induced liver injury. He did really well and was a good representative of the University Hospital and the University of Iceland.

A very important study by Einar Bjornsson and his team: what to expect from a patient with rectal bleeding. One fifth will have a rebleed, Age as riskfactor . No excess mortality! UEGJ my_UEG Nature Reviews Gastroenterology & Hepatology Endoscopy Journal Endoscopy Brothers & Sisters doi.org/10.1177/205064…

Fractures and Survival in Multiple Myeloma: Results from a Population-Based Study from Sigrun Thorsteinsdottir MD Department of Internal Medicine, Landspitali - The National University Hospital of Iceland #Myeloma #IMS #IMW2019

Sæmundur Rögnvaldsson, MD, PhD presents data on peripheral neuropathy (PN) in MGUS. A total of 6.5% have PN reflected in 2.7-fold risk compared to controls. MGUS w/PN are at a high risk of amyloidosis. Poster #215. Currently validating in #iStopMM #IMW19 C. Ola Landgren, M.D.

Sigrún Thorsteinsdottir presents the impact of fractures on myeloma survival. Fractures are still an important marker of MM severity. She defends her thesis on bone disease in MM and MGUS next week! #IMW2019 University of Iceland

What Sigurdur Kristinsson has done with the iStopMM trial in Iceland is just astonishing. Over 60,000 persons enrolled in a screening and prevention randomized trial for MGUS. Kudos! #ASH19 International Myeloma Foundation Yelak Biru

Historical Review: #CARTcells: continuation in a revolution of #immunotherapy thelancet.com/journals/lanon…

Very nice Editorial in Haematologica this month about bone disease in MM and our study 🙏 "The findings of Thorsteinsdottir et al. deserve the interest of interdisciplinary teams of MM experts" #mmsm Sigurdur Kristinsson Ingigerður Sólveig Thor Aspelund haematologica.org/content/105/4/…

Predicting the need for upfront bone marrow sampling in MGUS. @eliaseythorsson will tell you all about it in approx 3 hours. He will present a risk score that is available online! Don't miss it! #ASH22

What happens to MGUS and the M-protein after covid vaccination? Robert Palmason will tell you at 10 am today! iStopMM

If you screen 75,422 people for MGUS, what do you find? Thorvardur Jon Love will tell you in just 2 hours! iStopMM Binding Site International Myeloma Foundation

Today's oral presentations from the iStopMM team at #ASH @eliaseythorsson Thorvardur Jon Love Robert Palmason

Our article 'Prevalence of smoldering multiple myeloma based on nationwide screening' is out in Nature Medicine. A lot of work from the great iStopMM team behind this project ✨️ Sigurdur Kristinsson Sæmundur Rögnvaldsson, MD, PhD Malin Hultcrantz MD PhD @TBSsteharding C. Ola Landgren, M.D. nature.com/articles/s4159…

📢 Our team, led by Christian Brieghel, introduces the Real-World International Staging System (RW-ISS) — a new tool to enhance risk stratification for newly diagnosed MM patients in Blood Cancer Journal: 🧬 doi.org/10.1038/s41408… 🧮 Try RW-ISS online: rwiss.shinyapps.io/RWISS/ #RWISS #MMSM